newsfilter
← Latest News
ClinicalTrials.gov·

Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria - NCT05274633

Percentage Change In Lactate Dehydrogenase (LDH) From Baseline To End Of Observation, Percentage Change In LDH From Baseline To End Of Observation On Participants Treated With Ravulizumab With Respect To The Observed Treatment Period With Eculizumab, Number of Transfusions During Treatment Period With Ravulizumab, (and 9 more...)